HMR Priftin For TB In HIV Patients Needs Further Study- FDA Cmte.
Executive Summary
Hoechst Marion Roussel's tuberculosis drug Priftin needs additional investigation in HIV-infected patients regarding drug interactions and appropriate regimen, FDA's Antiviral Drugs Advisory Committee suggested on May 5.